July 2024

Turning back the years by turning down IL11

Turning back the years by turning down IL11

Low-level chronic inflammation is a hallmark of ageing. A recent article in Nature suggests the goals of longevity research to increase healthspan, as well as lifespan, may be achieved by simply inhibiting an inflammatory cytokine.

Read More

The RGD Peptide, origins and applications

The RGD Peptide, origins and applications

The RGD peptide is the most widely used in cell culture. RGD is a natural motif that binds to common cell receptors providing binding points to substrates. The origins and the myriad of applications of RGD are discussed.

Read More

Meet us at ISSCR in Hamburg

Meet us at ISSCR in Hamburg

We're attending ISSCR in Hamburg from 10-12 July Come and say hello and find out about our products and services. We're going to be featuring PODS, the 100% protein slow-release growth factors

Read More

How 3D bioprinters are advancing cancer research

How 3D bioprinters are advancing cancer research

Cancer is the second leading cause of death worldwide, after cardiovascular disease, with over 16.4 million cancer-related deaths predicted by 2040. It is well known for its complex and dynamic nature, which has meant that it is challenging to study with 2D cell culture models, although understanding of the disease has improved.

Read More

Improving cell therapy by in situ maturation

Improving cell therapy by in situ maturation

In autologous cell therapy, cells that originate in the patient are returned to the patient for therapeutic purposes. If we accept the obvious notion that human cells grow best in humans, the quicker cells can be re-implanted, the better. But many cells require complex, sustained manipulation to differentiate and mature into the cells required for therapeutic effect. Technologies that enable cells to differentiate and maturate autonomously in the patient following implant will enable this goal.

Read More